ALLMedicine™ Cholangitis Center

Jun 30th, 2017 - Clinicians are required to assess abnormal liver chemistries on a daily basis. The most common liver chemistries ordered are serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase and bilirubin. These tests sh...

Jul 9th, 2014 - The optimal management of treatment for patients at intermediate risk of a common duct stone (including increased liver function tests but bilirubin <4 mg/dL and no cholangitis) is a matter of debate. Many stones migrate spontaneously into the duo...

Feb 12th, 2014 - Ursodeoxycholic acid (UDCA) is no longer recommended for management of adult patients with primary sclerosing cholangitis (PSC). We undertook a prospective evaluation of UDCA withdrawal in a group of consecutive patients with PSC. Twenty six patie...

Feb 11th, 2017 - Up to 70% of patients with primary biliary cholangitis develop pruritus (itch) during the course of their disease. Treatment of pruritus in primary biliary cholangitis is challenging and novel therapies are needed. Ursodeoxycholic acid, the standa...

Sep 30th, 2013 - Little is known about nongenetic risk factors for primary sclerosing cholangitis (PSC), except a possible protective effect of smoking. We investigated the relationship between environmental risk factors and susceptibility to PSC. A questionnaire ...

Jan 31st, 2010 - This guideline has been approved by the American Association for the Study of Liver Diseases and represents the position of the Association. These recommendations provide a data‐supported approach.

Mar 27th, 2018 - Primary biliary cholangitis (formerly known as primary biliary cirrhosis, PBC) is an autoimmune liver disease in which a cycle of immune mediated biliary epithelial cell injury, cholestasis and progressive fibrosis can culminate over time in an en.

Oct 31st, 2018 - This American Association for the Study of Liver Diseases (AASLD) 2018 Practice Guidance on Primary Biliary Cholangitis (PBC) is an update of the PBC guidelines published in 2009. The 2018 updated guidance on PBC includes updates on etiology and d.

Jun 30th, 2017 - Clinicians are required to assess abnormal liver chemistries on a daily basis. The most common liver chemistries ordered are serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase and bilirubin. These tests sh...

Aug 2nd, 2018 - Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases.|2018|Lindor KD,Bowlus CL,Boyer J,Levy C,Mayo M,|complications,diagnosis,therapy,

This OCALIVA® (obeticholic acid) site is intended for US healthcare professionals only. See Prescribing Info & Boxed Warning.

Jan 31st, 2010 - This guideline has been approved by the American Association for the Study of Liver Diseases and represents the position of the Association. These recommendations provide a data‐supported approach.

Mar 27th, 2018 - Primary biliary cholangitis (formerly known as primary biliary cirrhosis, PBC) is an autoimmune liver disease in which a cycle of immune mediated biliary epithelial cell injury, cholestasis and progressive fibrosis can culminate over time in an en.

Oct 31st, 2018 - This American Association for the Study of Liver Diseases (AASLD) 2018 Practice Guidance on Primary Biliary Cholangitis (PBC) is an update of the PBC guidelines published in 2009. The 2018 updated guidance on PBC includes updates on etiology and d.

Jun 30th, 2017 - Clinicians are required to assess abnormal liver chemistries on a daily basis. The most common liver chemistries ordered are serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase and bilirubin. These tests sh...

Jun 30th, 2017 - Clinicians are required to assess abnormal liver chemistries on a daily basis. The most common liver chemistries ordered are serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase and bilirubin. These tests sh...

Aug 3rd, 2014 - Gallstones develop insidiously, and patients may remain asymptomatic for decades. Among symptomatic patients, gallstones can be challenging to diagnose and may be mistaken for irritable bowel disease, gastric reflux, or other diseases. If gallston...

Aug 17th, 2016 - Action Points Obeticholic acid (Ocaliva) administered for 1 year to patients with primary biliary cholangitis (PBC) performed better than placebo, in a phase III clinical trial. Note that an improvement in survival, progression to cirrhosis, or ot...

Apr 12th, 2018 - Action Points Note that this retrospective analysis of patients with primary biliary cirrhosis found that mirtazapine use was associated with significantly improved outcomes. Be aware that mirtazapine use overall was relatively uncommon in this co...

Dec 20th, 2011 - Action Points The frequency of liver transplantation for nonalcoholic steatohepatitis (NASH) increased six-fold over the past 15 years. Post-transplant survival of NASH patients proved superior to that of all but four other types of recipients: pr...